| scholarly article | Q13442814 |
| P50 | author | Maria O'Connell | Q53186665 |
| Susan Donath | Q39438266 | ||
| P2093 | author name string | F J Cameron | |
| E A Davis | |||
| T W Jones | |||
| P G Colman | |||
| D N O'Neal | |||
| G R Ambler | |||
| P2860 | cites work | Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system | Q46170043 |
| Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 | ||
| Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study | Q46420596 | ||
| A novel approach to continuous glucose analysis utilizing glycemic variation. | Q46460188 | ||
| Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes | Q50113907 | ||
| Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring | Q56093368 | ||
| The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial | Q71580033 | ||
| Continuous subcutaneous glucose monitoring in children with type 1 diabetes | Q31832735 | ||
| Continuous glucose monitoring in children with type 1 diabetes | Q36098103 | ||
| Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial | Q36351118 | ||
| Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial | Q36519725 | ||
| Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience | Q37130412 | ||
| The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients | Q39631923 | ||
| A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump | Q43580212 | ||
| A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects | Q43808984 | ||
| Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study | Q44157871 | ||
| The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control | Q44381371 | ||
| Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study | Q44427577 | ||
| Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system | Q44874898 | ||
| P433 | issue | 7 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| patient | Q181600 | ||
| P304 | page(s) | 1250-1257 | |
| P577 | publication date | 2009-04-25 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial | |
| P478 | volume | 52 |
| Q49582395 | A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. |
| Q37192444 | A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system |
| Q39044238 | A novel tool to predict youth who will show recommended usage of diabetes technologies. |
| Q35688182 | A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years |
| Q90166958 | Advances in technology for management of type 1 diabetes |
| Q36638904 | Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies? |
| Q26824430 | Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials |
| Q37492413 | Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial |
| Q42874742 | Closing the loop: another step forward |
| Q36605704 | Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. |
| Q39974199 | Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient Behavior |
| Q33786148 | Continuous Glucose Monitoring and Global Reimbursement: An Update |
| Q41196151 | Continuous Glucose Monitoring in Type 1 Diabetes |
| Q41662919 | Continuous Glucose Monitoring: Impact on Hypoglycemia. |
| Q38025974 | Continuous glucose monitoring in children and adolescents |
| Q46480535 | Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria |
| Q48050311 | Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). |
| Q47216039 | Continuous glucose monitoring in type 1 diabetes |
| Q38213046 | Continuous glucose monitoring system: Is it really accurate, safe and clinically useful? |
| Q24203866 | Continuous glucose monitoring systems for type 1 diabetes mellitus |
| Q38071016 | Continuous glucose monitoring: current clinical use. |
| Q30354773 | Continuous glucose monitoring: current use and future directions |
| Q27022628 | Continuous glucose monitoring: evidence and consensus statement for clinical use |
| Q42371739 | Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden |
| Q30455250 | Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons |
| Q38077933 | Demographic and personal factors associated with metabolic control and self-care in youth with type 1 diabetes: a systematic review |
| Q42360030 | Devices for continuous monitoring of glucose: update in technology |
| Q37054720 | Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress. |
| Q37275395 | Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). |
| Q55398504 | Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. |
| Q34718324 | Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes |
| Q47188852 | Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled on once daily basal insulin: a randomized, phase IV study |
| Q35337121 | Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials |
| Q53553958 | Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. |
| Q37972356 | Emergent technologies applied to diabetes: what do we need to integrate continuous glucose monitoring into daily practice? Where the long-term use of continuous glucose monitoring stands in 2011. |
| Q33873080 | Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial |
| Q37400821 | Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes |
| Q40022705 | Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing |
| Q33954163 | Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data |
| Q55252190 | Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis. |
| Q36159100 | High reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy |
| Q36159014 | HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Da |
| Q36638881 | Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year |
| Q35179907 | Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk |
| Q26785492 | Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update |
| Q89002574 | Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems |
| Q49887494 | Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes |
| Q35682802 | Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy |
| Q35224968 | New-generation diabetes management: glucose sensor-augmented insulin pump therapy |
| Q39633521 | No effect of yeast-like fungi on lipid metabolism and vascular endothelial growth factor level in children and adolescents with type 1 diabetes mellitus. |
| Q45955162 | Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. |
| Q64967573 | Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes. |
| Q35336885 | Real-life utilization of real-time continuous glucose monitoring: the complete picture |
| Q84974726 | Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE |
| Q31149131 | Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. |
| Q37851556 | Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review |
| Q37288497 | Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring |
| Q38771704 | Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting |
| Q36968348 | Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study |
| Q52817224 | Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients. |
| Q58886172 | Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial |
| Q35620189 | Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes |
| Q37054667 | The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes |
| Q30827667 | The Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed |
| Q88312391 | The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use |
| Q36942191 | The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial |
| Q35337585 | The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus |
| Q36353388 | The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial |
| Q37781158 | Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems |
| Q36475919 | Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring |
| Q37979361 | Use of continuous glucose monitoring in children and adolescents (*). |
| Q35594010 | Use of sensors in the treatment and follow-up of patients with diabetes mellitus. |
Search more.